Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Patient #16, #17 & #18

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison Jul 04, 2021 11:55am

335 Views

Post# 33490685

RE:Patient #16, #17 & #18

repost

99942Apophis wrote
Patient # 16 was announced treated in the news release dated March 25/2021 plus 90 days puts he or her at the end of June.
Patients # 17 & 18 were announced treated in the news release of April 27 plus 90 has them at the end of July.
Waiting with high hopes that these three parents will show CR (complete response) moving the average up and eventually meeting criteria for Fast Track and Breakthrough. Also looking for increases in enrolled/treated patients now that Covid-19 is moving into the rear-view mirror. In my biased opinion we are lining all the ducks up.

<< Previous

Bullboard Posts

Next >>

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity